Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Alx Oncology Holdings Inc (ALXO)

Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer GlobeNewswire - Thu Nov 14, 7:00AM CST

ALXO : 1.2200 (-5.43%)
ALX Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update GlobeNewswire - Thu Nov 7, 3:00PM CST

ALXO : 1.2200 (-5.43%)
ALX Oncology Announces November Investor Conference Participation GlobeNewswire - Mon Nov 4, 7:00AM CST

ALXO : 1.2200 (-5.43%)
ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024 GlobeNewswire - Fri Nov 1, 4:30PM CDT

ALXO : 1.2200 (-5.43%)
Why ALX Oncology Stock Is Skyrocketing Today Motley Fool - Tue Oct 3, 2023

Investors are cheering the immuno-oncology company's latest clinical trial results.

ALXO : 1.2200 (-5.43%)
Wall Street - shutterstock_1321462394
Stock Index Futures Plunge Ahead of U.S. JOLTs Report, U.S. Rates Stay in Focus Barchart - Tue Oct 3, 2023

December S&P 500 futures (ESZ23) are down -0.38%, and December Nasdaq 100 E-Mini futures (NQZ23) are down -0.50% this morning as market participants looked ahead to the release of fresh labor market data...

ESZ23 : 4,694.27s (-0.58%)
NQZ23 : 16,530.23s (-0.07%)
NVDA : 140.15 (-1.29%)
META : 554.40 (+0.06%)
GOOGL : 175.30 (+1.63%)
PODD : 260.68 (+0.22%)
K : 80.60 (+0.04%)
TGT : 156.56 (+2.91%)
BOO.LN : 29.660 (-1.13%)
ZAL.D.DX : 27.520 (+0.07%)
ALXO : 1.2200 (-5.43%)
ODD : 39.71 (-0.10%)
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation Investor Brand Network - Thu Sep 21, 2023

NetworkNewsWire Editorial Coverage : More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the development and evaluation...

GNPX : 1.3600 (-15.00%)
RHHBY : 35.7020 (-0.39%)
JAZZ : 117.59 (-3.34%)
ALXO : 1.2200 (-5.43%)
ACHL : 1.0500 (unch)
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation Investor Brand Network - Wed Sep 20, 2023

NetworkNewsWire Editorial Coverage : More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the development and evaluation...

GNPX : 1.3600 (-15.00%)
RHHBY : 35.7020 (-0.39%)
JAZZ : 117.59 (-3.34%)
ALXO : 1.2200 (-5.43%)
ACHL : 1.0500 (unch)
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation FinancialNewsMedia - Wed Sep 20, 2023

EQNX::TICKER_START (NASDAQ:GNPX),(OTCQX:RHHBY),(NASDAQ:JAZZ),(NASDAQ:ALXO),(NASDAQ:ACHL) EQNX::TICKER_END

GNPX : 1.3600 (-15.00%)
RHHBY : 35.7020 (-0.39%)
JAZZ : 117.59 (-3.34%)
ALXO : 1.2200 (-5.43%)
ACHL : 1.0500 (unch)
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation PR Newswire - Wed Sep 20, 2023

/PRNewswire/ -- More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the...

RHHBY : 35.7020 (-0.39%)
GNPX : 1.3600 (-15.00%)
JAZZ : 117.59 (-3.34%)
ALXO : 1.2200 (-5.43%)
ACHL : 1.0500 (unch)

Barchart Exclusives

Can Nvidia Stock Rally After Q3 Earnings This Week? Barchart - 36 minutes ago
Valued at a market cap of $3.5 trillion, Nvidia is a big tech giant that continues to grow at an enviable pace, even as major earnings beats have become routine. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot